
Chinese General Practice ›› 2020, Vol. 23 ›› Issue (7): 880-883.DOI: 10.12114/j.issn.1007-9572.2019.00.619
Special Issue: 肿瘤最新文章合辑; 共病最新文章合辑
• Monographic Research • Previous Articles Next Articles
Published:2020-03-05
Online:2020-03-05
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2019.00.619
| [1]BARY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer Journal for Clinicians,2018,68(6):1-31.DOI:10.3322/caac.21492. [2]兰蓝,赵飞,蔡玥,等.中国居民2015年恶性肿瘤死亡率流行病学特征分析[J].中华流行病学杂志,2018,39(1):32-34.DOI:10.3760/cma.j.issn.0254-6450.2018.01.006. LAN L,ZHAO F,CAI Y,et al.Epidemiological analysis on mortality of cancer in China,2015[J].Chinese Journal of Epidemiology,2018,39(1):32-34.DOI:10.3760/cma.j.issn.0254-6450.2018.01.006. [3]HOFFE S,BALDUCCI L.Cancer and age:general considerations[J].Clin Geriatr Med,2012,28(1):1-18.DOI:10.1016/j.cger.2011.09.001. [4]BRIGHI N,BALDUCCI L,BIASCO G.Cancer in the elderly:is it time for palliative care in geriatric oncology?[J].Journal of Geriatric Oncology,2014,5(2):197-203.DOI:10.1016/j.jgo.2014.01.007. [5]刘文斌.社区老年人高血压流行病学调查[J].中国全科医学,2011,14(3):300-302.DOI:10.3969/j.issn.1007-9572.2011.03.025. LIU W B.Epidemiological survey of hypertension in aged patients of the community[J].Chinese General Practice,2011,14(3):300-302.DOI:10.3969/j.issn.1007-9572.2011.03.025. [6]NQ H S,KOCZWARA B,RODER D,et al.Changes in the prevalence of comorbidity in the Australian population with cancer,2007—2014[J].Cancer Epidemiology,2018,54:56-62.DOI:10.1016/j.canep.2018.03.010. [7]MORISHIMA T,MIYASHIRO I,MATSUMOTO Y,et al.Impact of comorbidities on survival in gastric,colorectal,and lung cancer patients[J].Journal of Epidemiology,2018,14:1-6.DOI:10.2188/jea.JE20170241. [8]FEINSTEIN A R.The pre-therapeutic classification of co-morbidity in chronic disease[J].J Chron Dis,1970,23:455-468.DOI:10.1016/0021-9681(70)90054-8. [9]World Health Organization.The world health report 2008:primary health cared now more than ever[R].Geneva:World Health Organization,2008. [10]于普林.老年医学[M].北京:人民卫生出版社,2017. [11]MENESES K,BENZ R,AZUERO A,et al.Multimorbidity and breast cancer[J].Seminars in Oncology Nursing,2015,31(2):163-169.DOI:10.1016/j.soncn.2015.02.004. [12]崔瑶,刘谦,秦明照.老年共病现状及管理策略[J].中国全科医学,2017,20(23):2816-2819.DOI:10.3969/j.issn.1007-9572.2017.06.y54. CUI Y,LIU Q,QIN M Z.Status and management strategies of multiple chronic conditions in older adults[J].Chinese General Practice,2017,20(23):2816-2819.DOI:10.3969/j.issn.1007-9572.2017.06.y54. [13]周玉洁,吕启圆,李现文.共病及共病指数研究进展与应用展望[J].中国公共卫生,2015,34(11):1513-1516.DOI:10.11847/zgggws2015-31-11-44. ZHOU Y J,Lyu Q Y,LI X W.Comorbidity and comorbidity index:a review[J].Chin J Public Health,2015,34(11):1513-1516.DOI:10.11847/zgggws2015-31-11-44. [14]蒲莉蓉,王敏,李志雄,等.边缘型人格障碍与精神疾病共病的研究进展[J].中国神经精神疾病杂志,2019,45(4):250-253. PU L R,WANG M,LI Z X,et al.Research progress on comorbidity between borderline personality disorder and mental illness[J].Chinese Journal of Neuropsychiatric Diseases,2019,45(4):250-253. [15]KENZIK K M,KENT E E,MARTIN M Y.Chronic condition clusters and functional impairment in older cancer survivors:a population-based study[J].J Cancer Surviv,2016,10(6):1096-1103.DOI:10.1007/s11764-016-0553-4. [16]胡小兰.社区老年慢性非传染性疾病共病的现况调查[D].北京:首都医科大学,2015. [17]王飞虎,张璐.抗抑郁药治疗偏头痛与抑郁症共病的研究进展[J].中国乡村医药,2019,26(7):74-75.DOI:CNKI:SUN:XCYY.0.2019-07-048. WANG F H,ZHANG L.Research progress in the treatment of migraine and depression with antidepressant[J].Chinese rural medicine,2019,26(7):74-75.DOI:CNKI:SUN:XCYY.0.2019-07-048. [18]GUISADOCLAVERO M,ROSOLLORACH A,LóPEZJIMENEZ T,et al.Multimorbidity patterns in the elderly:a prospective cohort study with cluster analysis[J].BMC Geriatrics,2018,18(1):16.DOI:10.1186/s12877-018-0705-7. [19]WILLIAMS G R,DEAL A M,LUND J L,et al.Patient-reported comorbidity and survival in older adults with cancer[J].Oncologist,2017,23(4):1-7.DOI:10.1634/theoncologist.2017-0404. [20]METTE S,WERNICH T R,SKOVGAARD B K,et al.The impact of comorbidity on cancer survival:a review[J].Clinical Epidemiology,2013,5(1):3-29.DOI:10.2147/CLEP.S47150. [21]J?RGENSEN T L,HALLAS J,FRIIS S,et al.Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality[J].British Journal of Cancer,2012,106(7):1353-1360.DOI:10.1038/bjc.2012.46. [22]ALEXANDRA P T,AMAIA C L,JORGE H S,et al.Multimorbidity patterns:a systematic review[J].Journal of Clinical Epidemiology,2014,67:254-266.DOI:10.1016/j.jclinepi.2013.09.021. [23]OKEDIJI P T.The pattern of comorbidities in cancer patients in Lagos,South-Western Nigeria[J].Ecancer Medical Science,2018,12(843):1-12.DOI:10.3332/ecancer.2018.843. [24]WU A H,KURIAN A W,KWAN M L,et al.Diabetes and other comorbidities in breast cancer survival by race/ethnicity:the California Breast Cancer Survivorship Consortium(CBCSC)[J].Cancer Epidemiol Biomarkers Prev,2015,24(2):361-368.DOI:10.1158/1055-9965.EPI-14-1140. [25]XUE S,ZE C,WILSON K.Real-world treatment patterns,comorbidities,and disease-related complications in patients with multiple myeloma in the United States[J].Current Medical Research & Opinion,2016,32(1):95-103.DOI:10.1185/03007995.2015.1105202. [26]SARFATI D.Review of methods used to measure comorbidity in cancer populations:no gold standard exists[J].Journal of Clinical Epidemiology,2012,65(9):924-933.DOI:10.1016/j.jclinepi.2012.02.017. [27]GANTI A K,SIEDLIK E,MARR A S,et al.Predictive ability of charlson comorbidity index on outcomes from lung cancer[J].American Journal of Clinical Oncology,2011,34(6):593-596.DOI:10.1097/COC.0b013e3181fe445b. [28]CHARLSON M E,POMPEI P,ALES K L.A New method of classifving prognostic comorbidity in longitudinal studies:development and validation[J].J Chronic Dis,1987,40(5):373-383.DOI:10.1016/0021-9681(87)90171-8. [29]WU C,HSU T,CHANG C,et al.Age-adjusted Charlson comorbidity index scores as predictor of survival in colorectal cancer patients who underwent surgical resection and chemoradiation[J].Medicine,2015,94(2):e431.DOI:10.1097/MD.0000000000000431. [30]SINGH B,BHAYA M,STERN J,et al.Validation of the Charlson comorbidity index in patients with head and neck cancer:a multi-institutional study[J].The Laryngoscope,1997,107(11 Pt 1):1469-1475.DOI:10.1097/00005537-199711000-00009. [31]LEE J Y,LEE D H,CHO N H,et al.Impact of Charlson comorbidity index varies by age in patients with prostate cancer treated by radical prostatectomy:a competing risk regression analysis[J].Annals of Surgical Oncology,2014,21(2):677-683.DOI:10.1245/s10434-013-3326-6. [32]王灯英.某三甲医院住院患者营养状况与老年共病相关性及其干预研究[D].青岛:青岛大学,2017. [33]SARIFATI D,KOCZWARA B,JACKSON C.The impact of comorbidity on cancer and its treatment[J].A Cancer Journal for Clinicians,2016,66:337-350.DOI:10.3322/caac.21342. [34]AHN D H,MEHTA N,YORIO J T,et al.Influence of medical comorbidities on the presentation and outcomes of stage i-iii non-small-cell lung cancer[J].Clinical Lung Cancer,2013,14(6):644-650.DOI:10.1016/j.cllc.2013.06.009. [35]GRANN A F,FROSLEV T,OLESEN A B,et al.The impact of comorbidity and stage on prognosis of Danish melanoma patients,1987—2009:a registry-based cohort study[J].British Journal of Cancer,2013,109(1):265-271.DOI:10.1038/bjc.2013.246. [36]李苏宜,沈干.肿瘤患者的“共病”[J].中国临床保健杂志,2016,19(5):449-450.DOI:10.3969/J.issn.1672-6790.2016.05.001. LI S Y,SHEN G.Comorbidity of cancer patients[J].Chinese Journal of Clinical Health Care,2016,19(5):449-450.DOI:10.3969/J.issn.1672-6790.2016.05.001. [37]PETRILLO L A,RITCHIE C S.The challenges of symptom management for patients with multimorbidity in research and practice:a thematic review[J].Progress in Palliative Care,2016,24(5):262-267.DOI:10.1080/09699260.2016.1192320. [38]LEE L,CHEUNG W Y,ATKINSON E,et al.Impact of comorbidity on chemotherapy use and outcomes in solid tumors:a systematic review[J].J Clin Oncol,2011,29:106-117.DOI:10.1586/17474086.2015.1024650. [39]SARFATI D,GURNEY J,STANLEY J,et al.A retrospective cohort study of patients with stomach and liver cancers:the impact of comorbidity and ethnicity on cancer care and outcomes[J].BMC Cancer,2014,14:821.DOI:10.1186/1471-2407-14-821. [40]JORGENSEN T L,TEIBLUM S,PALUDAN M,et al.Significance of age and comorbidity on treatment modality,treatment adherence,and prognosis in elderly ovarian cancer patients[J].Gynecologic Oncology,2012,127(2):367-374.DOI:10.1016/j.ygyno.2012.07.001. [41]BRADLEY C J,DAHMAN B,ANSCHER M.Prostate cancer treatment and survival evidence for men with prevalent comorbid conditions[J].Medical care,2014,52:482-489.DOI:10.1097/MLR.0000000000000113. [42]KORENHAKIM T,WEISS A,HERSHKOVITZ A,et al.The relationship between nutritional status of hip fracture operated elderly patients and their functioning,comorbidity and outcome[J].Clinical Nutrition,2012,6(1):917-921.DOI:10.1016/j.clnu.2012.03.010. [43]SOGAARD M,THOMSEN R,BOSSEN K,et al.The impact of comorbidity on cancer survival:a review[J].Clin Epidemiol,2013,5:3-29.DOI:10.2147/CLEP.S47150. [44]TüZüN H,AYCAN S,LHAN M N.Impact of comorbidity and socioeconomic status on quality of life in patients with chronic diseases who attend primary health care centres[J].Central European Journal of Public Health,2015,23(3):188-194.DOI:10.21101/cejph.a3990. [45]BACKEMAR L,WIKMAN A,DJ?RV T,et al.Co-morbidity after oesophageal cancer surgery and recovery of health-related quality of life[J].British Journal of Surgery,2016,103(12):1665-1675.DOI:10.1002/bjs.10248. [46]DOUNYA S,KAMILA C,PER H.The Impact of co-morbidity on health-related quality of life in breast cancer survivors and controls[J].Acta Oncologica,2015,54(5):727-734.DOI:10.3109/0284186X.2014.998277. [47]VISSERS P A,THONG M S,POUWER F,et al.The impact of comorbidity on health-related quality of life among cancer survivors:analyses of data from the profiles registry[J].J Cancer Surviv,2013,7:602-613.DOI 10.1007/s11764-013-0299-1. [48]WILLIAMS G R,MACKENZIE A,MAGNUSON A,et al.Comorbidity in older adults with cancer[J].Journal of Geriatric Oncology,2015,7(4):249-257.DOI:10.1016/j.jgo.2015.12.002. LIU S.The phenomenon of "abuse of the elderly" in China,its causes and countermeasures[J].Chinese Journal of Gerontology,2016,36(1):221-223. |
| [1] | LI Wenping, CHEN Jianhua, XU Jiapei, JIN Xue, PAN Zihan, CHI Chunhua. A Scoping Review on the Empowerment of Community Elderly Health Services by Digital-Intelligent Health Management Platforms [J]. Chinese General Practice, 2026, 29(21): 2938-2949. |
| [2] | FENG Zhenzhen, LIU Wenrui, LI Jiansheng, GUAN Xutao, QUAN Jianfeng, GAO Hong, TIAN Jianhui, RONG Zhen, HOU Wei, ZHOU Xun. Research on the Differences in the Clinical Characteristics and Basic Pattern Distribution of 2 340 Lung Cancer Patients in Different Regions of China [J]. Chinese General Practice, 2026, 29(20): 2860-2866. |
| [3] | FAN Meixiang, YAN Yunyun, HUANG Yanyan. Interpretation and Discussion of Guidelines for Preventive Activities in General Practice: Bladder Cancer [J]. Chinese General Practice, 2026, 29(18): 2450-2453. |
| [4] | MA Xiaoyu, MA Xiaomei, WU Guozhi, ZHENG Ya, GUO Qinghong. Research Progress of Neutrophil Extracellular Traps in Gastric Cancer [J]. Chinese General Practice, 2026, 29(17): 2425-2432. |
| [5] | CHEN Yan, SHEN Dequan, SHENG Renlei, CHANG Yujie, YANG Jiaqi, DING Jie, SUN Zhifang, WANG Dahui. Influencing Factors and Importance Ranking of the Utilization of Primary-level Traditional Chinese Medicine Preventive and Health Care Services for the Elderly [J]. Chinese General Practice, 2026, 29(16): 2182-2189. |
| [6] | ZHENG Zelu, ZHOU Jun, LIANG Zhi, WANG Xuehui, XU Feng, LI Oujing, XIAO Hong, LIU Xiaoyu, YANG Qingmei, ZHANG Mei, LIN Na, MI Baohong, CHEN Weiheng. Comorbidity Profiles and Treatment Patterns of Osteoarthritis Patients: a Cross-sectional Study Based on Community Medical Records [J]. Chinese General Practice, 2026, 29(16): 2205-2213. |
| [7] | XU Ping, MA Yan, HUANG Li, HE Meiliang, HOU Yunfeng, WANG Dewang, SUN Panpan, LIU Zheng, GUO Yanfang, XU Ying. Association between Weight-adjusted Waist Index and Comorbidity of Hypertension, Diabetes and Dyslipidemia in Community-dwelling Adults [J]. Chinese General Practice, 2026, 29(16): 2198-2204. |
| [8] | ZHENG Renkuo, HUA Fei. The Correlation between Metabolic Dysfunction-associated Steatotic Liver Disease and Papillary Thyroid Carcinoma [J]. Chinese General Practice, 2026, 29(15): 2029-2036. |
| [9] | QIU Yanli, GAO Yongyin, BIAN Xueyan, WANG Xue, LI Yue. The Predictive Value of Estimated Pulse Wave Velocity for All-cause and Cardiovascular-related Mortality in Cancer Patients [J]. Chinese General Practice, 2026, 29(14): 1890-1897. |
| [10] | LI Zhen, WANG Chengyong. Association of Neutrophil-to-lymphocyte Ratio, Systemic Immune-inflammation Index, and Monocyte-to-lymphocyte Ratio with Disease Prognosis in Patients with Advanced Prostate Cancer [J]. Chinese General Practice, 2026, 29(14): 1878-1882. |
| [11] | XIONG Siyu, LU Bing, JIANG Wenhong, YU Tingting. Study on the Relationship between Fructose-1, 6-Bisphosphate Aldolase A Expression before and after Targeted Drug Resistance in Lung Adenocarcinoma and Patient Prognosis [J]. Chinese General Practice, 2026, 29(14): 1883-1889. |
| [12] | YUAN Weixia, AO Panpan, MA Yun, WU Fengfu, XU Facui, YU Juan, ZENG Qun, WEI Shaofeng, YUAN Lijia. The Predictive Value of Age-adjusted Charlson Comorbidity Index for Sarcopenia in Older Adults [J]. Chinese General Practice, 2026, 29(13): 1673-1681. |
| [13] | GU Handong, LU Hongrun, GU Keyi, HAN Zheng, YANG Fei, FU Xiaoya, WANG Weiqiang. Association Research between Relative Fat Mass and the Incidence Risk of Cardiometabolic Multimorbidity [J]. Chinese General Practice, 2026, 29(11): 1456-1462. |
| [14] | WANG Fei, HAN Weiyu, SUN Tao. Moxibustion Combined with Three-step Therapy in the Treatment of Cancer Pain: a Network Meta-analysis [J]. Chinese General Practice, 2026, 29(09): 1203-1211. |
| [15] | SHI Jiaqi, WANG Yuxin, LUO Jiani, JIANG Qi, WU Shanyu, JIN Toufeng. Factors Influencing Symptom Clusters in Patients with Gastrointestinal Cancers: a Scoping Review [J]. Chinese General Practice, 2026, 29(05): 668-675. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||